A recent TechCrunch article revealed that TraceLink has closed a $51.5 million Series C round led by Goldman Sachs Growth Equity. The deal places Goldman among other prestigious investors who have put their faith and funds into the 2009 startup including FirstMark Capital, Volition Capital, and F-Prime Capital. Goldman’s Jason Kreuziger will join TraceLink’s board of directors as part of the deal. A statement from TraceLink CEO, Shabbir Dahod, can be read here.
Goldman Sachs Leads $50M+ TraceLink Round
TraceLink closes Series C financing to help companies comply with country-specific track-and-trace requirements.
Dec 6, 2016
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
